Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy

L Palmerston Mendes, J Pan, VP Torchilin - Molecules, 2017 - mdpi.com
Dendrimers are highly branched polymers with easily modifiable surfaces. This makes them
promising structures for functionalization and also for conjugation with drugs and DNA/RNA …

PAMAM dendrimer nanomolecules utilized as drug delivery systems for potential treatment of glioblastoma: a systematic review

M Fana, J Gallien, B Srinageshwar… - International journal …, 2020 - Taylor & Francis
Glioblastoma (GB) is a grade IV astrocytoma that maintains a poor prognosis with respect to
current treatment options. Despite major advancements in the fields of surgery and …

Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer

Z Zhao, Y Li, H Liu, A Jain, PV Patel, K Cheng - Science advances, 2020 - science.org
IKBKE is an oncogene in triple-negative breast cancer (TNBC), and we demonstrate that
IKBKE small interfering RNA (siRNA) inhibits the proliferation, migration, and invasion of …

Survivin as a novel target protein for reducing the proliferation of cancer cells

D Li, C Hu, H Li - Biomedical reports, 2018 - spandidos-publications.com
Survivin, also known as baculoviral inhibitor of apoptosis repeat‑containing 5, is a novel
member of the inhibitor of apoptosis protein family. Survivin is highly expressed in tumors …

Clathrin mediated endocytosis is involved in the uptake of exogenous double-stranded RNA in the white mold phytopathogen Sclerotinia sclerotiorum

N Wytinck, DS Sullivan, KT Biggar, L Crisostomo… - Scientific reports, 2020 - nature.com
RNA interference (RNAi) technologies have recently been developed to control a growing
number of agronomically significant fungal phytopathogens, including the white mold …

Dendrimers as carriers for siRNA delivery and gene silencing: a review

J Wu, W Huang, Z He - The Scientific World Journal, 2013 - Wiley Online Library
RNA interference (RNAi) was first literaturally reported in 1998 and has become rapidly a
promising tool for therapeutic applications in gene therapy. In a typical RNAi process, small …

Induction of cytokines by nucleic acid nanoparticles (NANPs) depends on the type of delivery carrier

YI Avila, M Chandler, E Cedrone, HS Newton… - Molecules, 2021 - mdpi.com
Recent insights into the immunostimulatory properties of nucleic acid nanoparticles (NANPs)
have demonstrated that variations in the shape, size, and composition lead to distinct …

Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels

AP Perez, C Mundiña-Weilenmann… - International journal …, 2012 - Taylor & Francis
Background Molecules taken up by olfactory and trigeminal nerve neurons directly access
the brain by the nose-to-brain pathway. In situ-forming mucoadhesive gels would increase …

Are caveolae a cellular entry route for non-viral therapeutic delivery systems?

PV Rewatkar, RG Parton, HS Parekh… - Advanced drug delivery …, 2015 - Elsevier
The development of novel therapies increasingly relies on sophisticated delivery systems
that allow the drug or gene expression-modifying agent of interest entry into cells. These …

Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex

RS Shukla, A Jain, Z Zhao, K Cheng - … : Nanotechnology, Biology and …, 2016 - Elsevier
Despite the importance of siRNA delivery systems, understanding of their intracellular fate
remains elusive. We recently developed a multi-component siRNA nanocomplex to deliver …